Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-05-26

Clinical Trial Update: Tiotropium for Smoking Asthmatics Study [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating tiotropium in smokers with asthma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tiotropium (tiotropium)

Snippet

Sponsor: University of Alberta | Conditions: Asthma | Phase 4 | Status: WITHDRAWN